Merit Medical Systems (MMSI) Cost of Revenue (2010 - 2026)

Merit Medical Systems (MMSI) has 17 years of Cost of Revenue data on file, last reported at $197.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 7.5% year-over-year to $197.1 million; the trailing twelve-month figure through Mar 2026 stood at $791.4 million (up 9.2% YoY), and the FY2025 full-year result was $777.6 million, up 9.04% from the prior year.
• Cost of Revenue eased to $197.1 million in Q1 2026, from $198.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $198.6 million in Q4 2025 to a low of $154.5 million in Q1 2022.
• A 5-year average of $176.1 million and a median of $174.0 million in 2023 frame the typical range for Cost of Revenue.
• Peak annual rise in Cost of Revenue reached 12.76% in 2022, while the deepest fall reached 2.38% in 2022.
• Tracing MMSI's Cost of Revenue over 5 years: stood at $158.9 million in 2022, then grew by 9.52% to $174.0 million in 2023, then increased by 4.71% to $182.2 million in 2024, then increased by 9.01% to $198.6 million in 2025, then decreased by 0.76% to $197.1 million in 2026.
• Business Quant data shows MMSI's Cost of Revenue at $197.1 million in Q1 2026, $198.6 million in Q4 2025, and $197.7 million in Q3 2025.